Therapix Biosciences Ltd (TRPX)

0.317  -0.3 (-48.9%)

After market: 0.305 -0.01 (-3.79%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Therapix Biosciences Ltd

NASDAQ:TRPX (7/1/2020, 7:22:21 PM)

After market: 0.305 -0.01 (-3.79%)

0.317

-0.3 (-48.9%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap1.11M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

TRPX Daily chart

Company Profile

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.

Company Info

Therapix Biosciences Ltd

4 ARIEL SHARON STREET HASHAHAR TOWER 16TH FLOOR

GIVATAYIM L3 5320047

P: 972-3616-7055

CEO: Gilad Bar-Lev

TRPX News

News Image4 years ago - Seeking AlphaTherapix Biosciences replaces board (NASDAQ:TRPX)

Struggling cannabinoid-based treatment developer Therapix Biosciences (NASDAQ:TRPX) has replaced its entire six-member board of directors.Itschak Shrem is the new chairman.Nasdaq delisted its ADSs on July 2.

News Image4 years ago - Therapix Biosciences Ltd.Therapix Biosciences Announces Replacement of its Board of Directors
News Image4 years ago - StockNews.comBest & Worst Performing Small Cap Stocks for July 20, 2020

MJCO – MJCO leads the way today as the best performing small cap stock, closing up 72.25%.

News Image4 years ago - StockNews.comBest & Worst Performing Small Cap Stocks for July 17, 2020

VRNA – VRNA leads the way today as the best performing small cap stock, closing up 115.64%.

News Image4 years ago - StockNews.comBest & Worst Performing Small Cap Stocks for July 16, 2020

AHT – AHT leads the way today as the best performing small cap stock, closing up 813.11%.

News Image4 years ago - StockNews.comBest & Worst Performing Small Cap Stocks for July 15, 2020

GENE – GENE leads the way today as the best performing small cap stock, closing up 143.81%.

TRPX Twits

Here you can normally see the latest stock twits on TRPX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example